Stem cells, CRISPR/Cas9 explored for possible HIV treatment

“Berlin Patient” Timothy Brown was cured of HIV after he received stem cells from a patient naturally immune to the disease. His story inspired two companies to try and recreate that natural immunity in HIV patients using stem cells and two (then-new) gene-editing techniques.

The approach has proven so popular that long before conclusive clinical trial results are due in, a third team has entered the fray: Harvard University. Harvard is using stem cells and the hottest gene-editing newcomer of all: CRISPR/Cas9.

Researchers behind all three approaches are highly confident in their respective approaches, they told Bioscience Technology this week. The clear impression each left: few stones will remain unturned in the high-tech quest to replicate the simple— if stunning— success of the Berlin Patient.

Read full, original article: Fighting HIV with Stem Cells and Cutting-edge Genetics

Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Here’s where GM crops are grown around the world today

Infographic: Here’s where GM crops are grown around the world today

Do you know where biotech crops are grown in the world? This updated ISAAA infographics show where biotech crops were ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
Send this to a friend